Hunan Kelun Pharmaceutical
Clinical trials sponsored by Hunan Kelun Pharmaceutical, explained in plain language.
Hunan Kelun Pharmaceutical is a Chinese pharmaceutical company producing generic and innovative drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Healthy volunteers needed to test safety of experimental drug KLA478 Results expected Sep 2026 (estimated)
- New sedative candidate goes Head-to-Head with propofol in early human test Results expected Nov 2026 (estimated)
-
New drug KLA578-1 tested in healthy people for first time
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called KLA578-1 in 48 healthy volunteers aged 18 to 45. The main goal is to check if the drug is safe and how the body processes it. Participants will receive either a single dose or multiple doses, and researchers will monitor for side eff…
Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Healthy volunteers needed to test new Injection's safety
Knowledge-focused Recruiting nowThis early-stage study tests whether a new drug called KLA318-2 is safe and how the body processes it. About 48 healthy adults aged 18-45 will receive a single injection. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.
Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Healthy volunteers needed to test experimental Injection's safety
Knowledge-focused Recruiting nowThis early-stage study tests a single dose of an experimental drug called KL0011034 in 76 healthy Chinese volunteers aged 18-45. The main goal is to check for side effects and how the drug moves through the body. Participants are randomly assigned to receive the drug, a placebo, …
Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Healthy volunteers needed to test safety of experimental drug KLA478
Knowledge-focused Recruiting nowThis early-stage study tests whether a single dose of KLA478 is safe and how the body processes it. About 40 healthy adults aged 18-45 will receive the drug and be monitored for side effects and drug levels in the blood. No treatment benefit is expected; the goal is to gather saf…
Phase 1 • Sponsor: Hunan Kelun Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC